The educational objectives of SSM11 are:
- To provide an in depth perspective of the drug discovery process at the beginning of the XXIst century, from basic research of disease pathways to the rational design of safe and effective molecules with appropriate drug-like properties.
- To offer an overview of drug development from proof of concept (POC) to registration.
- To introduce issues of market access documentation needs following registration, together with approaches to their early identification and integration into the overall product development plan.
Easy access to experts and speakers is an important feature of SSM.
The program includes oral and poster sessions where participants may present their research and discuss with colleagues how their own research fits in the continuum of drug discovery.
Participants will benefit from a personalized visit to the state of the art drug discovery facilities of IRIC (Institut for Research in Immunology and Cancer), one of the most renowned Center in translational research in Canada.
Participants will attend the Annual Discovery to Development Industrial Symposium, where they will have an opportunity to network with drug development specialists in Montreal, a city which ranks 10th among North America’s largest metropolitan areas in the life science and health technologies sector.